AzTrials
AzTrials

PainPhase 4NCT00805623

Sucking and Sucrose as Pain Relief for Infants

A Phase 4 study testing sucrose in people with Pain, run by Rabin Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Sucking and sucrose have been shown to reduce pain during venous puncture in neonates. Our study is designed to see if sucking and sucrose relieve pain during venous puncture in infants age 3-12 months. Read more about this study

Who is it for?
Ages 3 to 12 months
Conditions the study is for
Pain
What is being tested?
sucrose
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteIsrael
Study dates
Mar 2009to Oct 2009
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 12 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • age 3-12 months
  • hospitalized in pediatric ward B
  • need venous puncture

Who cannot join

  • neurological deficit
  • developmental delay
  • Cyanotic heart disease
  • symptomatic respiratory disease
  • known problematic venous access

Trial locations and contacts

1 site in 1 country.

Vered Hofer, MD contact

972-3-9253681

veredho@clalit.org.il

Rachel Efrat, MD contact

972-3-9253279

pedpain@clalit.org.il

Israel1 site
  • Schneider Children's Medical Center of Israel

    Petah Tikva, 49202

Other trials in Israel

About this study

Official title: Partial Blinded Controlled Study to Compare SucroseVs Water, With and Without Pacifier as Pain Reliever During Venous Puncture in Infants 3-12 Months Old

Sucking and sucrose have been shown to reduce pain during venous puncture in neonates. Our study is designed to see if sucking and sucrose relieve pain during venous puncture in infants age 3-12 months.

Read the detailed description

100 infants age 3-12 months old without neurologic, developmental or cardio-respiratory impairment, needing venous puncture for IV access, or blood aspiration, will be randomly assigned to one of 2 groups - with or without pacifier. During the puncture, each patient with pacifier will receive either 1 cc of water or 1 cc of sucrose (the solutions prepared and marked blindly) . Each patient without pacifier 2 will receive 1 cc of water without pacifier,will receive either 1 cc of water or 1 cc of sucrose (the solutions prepared and marked blindly). FLACC pain score will be used for apin assessment before, during and after the puncture.Comparison of the four groups will be done after the end of the study.

Conditions
Pain
Being tested
sucrose
Keywords
sucrose, sucking, pain relief, infant, require venous puncture
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • sucroseDietary supplement

    Also called no other name

    1 cc of sucrose 33.5% with or without pacifier

Study groups in NCT00805623
Study groupRoleWhat they receive
AWNo interventionno pacifier , no sucrose
ASActive comparatorsucrose without pacifier
Receives: Dietary Supplement: sucrose
PWNo interventionNot described
PSExperimentalPacifier and sucrose interventional
Receives: Dietary Supplement: sucrose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. reduced pain scoring

    Measured: 10 minutes

Secondary outcomes (1)
  1. better Parent's scoring to the child's behavior

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2008 (estimated)
  2. Study startMar 2009
  3. Primary completionAug 2009 (estimated)
  4. Study completionOct 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00805623
Sponsor's protocol ID
004994
Status last verified
Dec 2008
First submitted
7 Dec 2008
Last updated
9 Dec 2008
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing sucrose in people with Pain, run by Rabin Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Dec 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Vered Hofer, MD (972-3-9253681, veredho@clalit.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

reduced pain scoring (time frame: 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in